Adaptin Bio (APTN) Non Operating Income (2024 - 2026)

Adaptin Bio's Non Operating Income history runs 3 years deep, the most recent figure standing at -$1943.0 for Q1 2026.

• In Q1 2026, Non Operating Income fell 100.79% year-over-year to -$1943.0; the TTM figure through Mar 2026 stood at -$1943.0 (up 99.27% YoY), while the FY2025 annual figure was $247374.0, up 144.76% from the prior year.
• Non Operating Income came in at -$1943.0 for Q1 2026 at Adaptin Bio, down from $247374.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $247374.0 in Q1 2025 to a low of -$348756.0 in Q4 2024.
• A 3-year average of -$51206.8 and a median of -$45557.0 in 2024 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income surged 723.17% in 2025 and plunged 100.79% in 2026, its largest moves.
• Adaptin Bio's Non Operating Income stood at -$348756.0 in 2024, then soared by 170.93% to $247374.0 in 2025, then tumbled by 100.79% to -$1943.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered -$1943.0, $247374.0, and -$348756.0 for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison